Our
story.

In 2022, our founder watched a close friend — a healthy, athletic forty-two-year-old — die of a sudden heart attack. Six months earlier, her annual physical had returned "all normal." Standard cholesterol panel. Standard blood pressure. Standard everything.

What her physical didn't measure: ApoB. Lp(a). Fasting insulin. hs-CRP. The five or six biomarkers that, taken together, would have made her risk visible years in advance.

The technology to measure these biomarkers has existed for decades. The peer-reviewed evidence has been clear for nearly as long. And yet a typical primary-care visit still measures the same eighteen markers it did in 1995, because that's what insurance reimburses.

Osiro Health exists to close that gap. We measure 110+ biomarkers — the ones the best longevity clinics in the world measure — and we make the experience feel less like a doctor's appointment and more like the gold standard of care it deserves to be.

We are not a replacement for your physician. We are the layer of preventive insight that should have existed all along.

Our principles

Three commitments
we won't compromise.

Every decision at Osiro — from which lab partners we use to how we write your results summary — runs through these three filters.

Principle i

Measure deeply.

The body is a system of systems. A panel that measures eighteen markers tells you almost nothing. A panel that measures 110+ tells you the truth. We refuse to ship anything less.

Principle ii

Interpret personally.

Numbers without context are just noise. Every Osiro panel is reviewed by a licensed clinician who writes you a personal summary. No PDF dumps. No algorithm-only interpretations.

Principle iii

Respect always.

Your health data is the most intimate data you have. We store it under HIPAA-grade encryption, we never sell it, and you can export or delete the entire record with one click.

The team

Clinicians, scientists, builders.

Our founding team brings together Harvard Medical, Imperial College, and engineers from Apple Health, Stripe, and Verily.

EC

Dr. Elena Cortazar, MD

Co-founder · CMO

Internal medicine, ten years at Brigham & Women's. Trained in preventive cardiology at the Cleveland Clinic.

JR

Jordan Reyes

Co-founder · CEO

Former product lead at Apple Health. Wrote his MIT thesis on bayesian inference in clinical decision support.

AS

Dr. Amara Sundberg, PhD

Head of Science

Longevity researcher, formerly Buck Institute on Aging. Twenty-eight peer-reviewed papers on biomarkers of aging.

KO

Kai Okonkwo

Head of Engineering

Built infrastructure at Stripe and the early team at Verily. Cares about HIPAA the way most people care about plot twists.

MV

Dr. Marisol Vela, MD

Head of Clinical Care

Endocrinologist, ten years at UCSF. Oversees every clinician on the Osiro care team.

HT

Hana Tanaka

Head of Design

Previously design lead at Notion and Calm. Believes that beautiful design is a form of clinical care.

Scientific advisory

Guidance from the field's
most respected minds.

Every panel and every reference range is reviewed quarterly by our scientific advisory board — physicians and researchers from the institutions setting the standard in preventive medicine.

Dr. Peter Halvorsen

Preventive cardiology

Chair, LipidologyCleveland HeartLab

Dr. Sarah Kelleher, MD

Endocrinology & metabolism

DirectorStanford Longevity Lab

Dr. Anand Nair, MBBS

Functional medicine

Senior LecturerImperial College London

Dr. Yuki Tanaka, PhD

Epigenetics, biological age

Principal InvestigatorRIKEN

Dr. Olivia Pemberton-Wright

Hormonal health

Consultant EndocrinologistRoyal Marsden

Dr. James Okafor, MD

Internal medicine

Associate ProfessorJohns Hopkins
Our path so far

A short timeline.

2022

The idea

Founded after a personal loss made the gap between possible and standard care impossible to ignore.

2023

First clinical pilot

Built our reference framework with 200 members in partnership with two academic clinics.

2024

Lab integration

Established direct integrations with Quest, Labcorp, Boston Heart and Cleveland HeartLab.

2025

Seed round

Closed a $14M seed round to expand the clinical care team and open in five new countries.

2026

Public waitlist

Opening membership in waves. The waitlist is where it begins.

By the numbers

Where we are today.

14 Clinicians on staff
2,000+ Partner draw sites
22,000 Panels on waitlist
$14M Seed funding raised
The next step

Become a part of what's coming.

Membership opens in waves. Reserve your place to lock in founder pricing and priority access.

Join the waitlist